The need for improved medical management of patients with concomitant hypertension and type 2 diabetes mellitus

American Journal of Managed Care

Volumn 11, Issue 4, 2005, Pages 206-210

  Godley, Paul J ^a   Maue, Susan K ^b   Farrelly, Eileen W ^b   Frech, Feride ^c  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b XCENDA   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; DATA ANALYSIS; DATA BASE; HEALTH CARE NEED; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; HYPERTENSION; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SAMPLING;

AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPERTENSION; INSURANCE, HEALTH; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 17644365734     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Department of Health and Human Services Web site. HHS, American Diabetes Association renew campaign to help people with diabetes know their cardiovascular risks: new ADA survey shows many know little about risks of heart disease, stroke [press release]. February 19, 2002. Available at: http://www.hhs.gov/news/press/2002pres/20020219.html. Accessed September 16, 2003.
2. Bakris GL, Williams M, Dworkin L, et al; National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis. 2000;36:646-661.
3. Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care. 2001;24:1522-1527.
4. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37:1053-1059.
5. Gerstein HC, Mann JF, Yi Q, et al; HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421-426.
6. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KMV. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136:565-574.
7. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
8. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2571.
9. American Diabetes Association. Hypertension management in adults with diabetes. Diabetes Care. 2004;27(suppl 1):S65-S67.
10. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2004;27(suppl 1):S15-S35.
11. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and the National High Blood Pressure Education Program Coordinating Committee. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
12. Godley P, Pham H, Rohack J, Woodward B, Yokoyama K, Maue SK. Opportunities for improving the quality of hypertension care in a managed care setting. Am J Health Syst Pharm. 2001;58:1728-1733.
13. Godley P, Nguyen A, Yokoyama K, Rohack J, Woodward B, Chiang T. Improving hypertension care in a large group-model MCO. Am J Health Syst Pharm. 2003;60:554-564.
14. American Diabetes Association. Standards of medical care for patients with diabetes mellitus: Clinical Practice Recommendations 2001. Diabetes Care. 2001;24(suppl 1):S33-S43.
15. Grant RW, Cagliero E, Murphy-Sheehy P, Singer DE, Nathan DM, Meigs JB. Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes. Am J Med. 2002;112:603-609.
16. Coon P, Zulkowski K, Adherence to American Diabetes Association standards of care by rural health care providers. Diabetes Care. 2002;25:2224-2229.
17. George PB, Tobin KJ, Corpus RA, Devlin WH, O'Neill WW. Treatment of cardiac risk factors in diabetic patients: how well do we follow the guidelines? Am Heart J. 2001;142:857-863.
18. McFarlane SI, Jacober SJ, Winer N, et al. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care. 2002;25:718-723.
19. Singer GM, Izhar M, Black HR. Guidelines for hypertension: are quality-assurance measures on target? Hypertension. 2004;43:198-202.
20. Berlowitz DR, Ash AS, Hickey EC, Glickman M, Friedman R, Kader B. Hypertension management in patients with diabetes: the need for more aggressive therapy. Diabetes Care. 2003;26:355-359.
21. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. Circulation. 1998;97:2099-2100.
22. Gregg EW, Gerzoff RB, Caspersen CJ, Williamson DF, Venkat Narayan KM. Relationship of walking to mortality among US adults with diabetes. Arch Intern Med. 2003;163:1440-1447.
23. American Diabetes Association. Smoking and diabetes. Diabetes Care. 2003;26(suppl 1):S89-S90.
24. Lu WX, Lakkis J, Weir MR. Optimizing target-organ protection in patients with diabetes mellitus: angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Curr Hypertens Rep. 2003;5:192-198.
25. Swales P, Williams B. Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT1-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension. J Renin Angiotensin Aldosterone Syst. 2002;3:79-89.
26. Gradman AH, Acevedo C. Evolving strategies for the use of combination therapy in hypertension. Curr Hypertens Rep. 2002;4:343-349.